Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results

See more here


Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update

See more here


Relmada Therapeutics Announces Publication of REL-1017 Preclinical Data in Frontiers in Pharmacology

See more here


Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging

Collaboration to Develop Pharmacodynamic Biomarkers for Buntanetap

See more here


Scripps Health and UT Health San Antonio purchase Oncora’s software to improve physician documentation and enhance personalized cancer care

See more here


Melior Announces Substantial Additions to Its Management and Scientific Team 

• Dr. Ken Kilgore joins Melior as VP of Scientific Operations

• Dr. Hongyan Li joins Melior as Director of Oncology

• Dr. Vivian Cong rises to VP of Research & Development

See more here


WellTrackONE Corporation releases Targeted Risk Adjustment Coding system (TRAC)

TRAC will help with HCC RAF scores, lost revenue opportunities and avoidance of RAC/RADV audit penalties

See more here


Venatorx Pharmaceuticals Raises Series C Financing Led by the AMR Action Fund

See more here